Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection’s limited influence on overall survival, ATRX as molecular prognosticator
Neuro-Oncology · 05.08.2024 · 26 (8) · 1479-1493
DOI: 10.1093/neuonc/noae061 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Neuro-Oncology, online erschienen am 20.03.2024. Verfasst von Alice Ryba und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Glioma, X-linked Nuclear Protein, Mutation, Brain Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
H3 K27M-mutated gliomas were first described as a new grade 4 entity in the 2016 World Health Organization classification. Current studies have focused on its typical appearance in children and young adults, increasing the need to better understand the prognostic factors and impact of surgery on adults. Here, we report a multicentric study of this entity in adults.
Methods
We included molecularly confirmed H3 K27M-mutated glioma cases in patients ≥ 18 years diagnosed between 2016 and 2022. Clinical, radiological, and surgical features were analyzed. Univariate and multivariate analyses were performed to identify prognostic factors.
Results
Among 70 patients with a mean age of 36.1 years, the median overall survival (OS) was 13.6 ± 14 months. Gross-total resection was achieved in 14.3% of patients, whereas 30% had a subtotal resection and 54.3% a biopsy. Tumors located in telencephalon/diencephalon/myelencephalon were associated with a poorer OS, while a location in the mesencephalon/metencephalon showed a significantly longer OS (8.7 vs. 25.0 months, P = .007). Preoperative Karnofsky-Performance Score (KPS) ≤ 80 showed a reduced OS (4.2 vs. 18 months, P = .02). Furthermore, ATRX loss, found in 25.7%, was independently associated with an increased OS (31 vs. 8.3 months, P = .0029). Notably, patients undergoing resection showed no survival benefit over biopsy (12 vs. 11 months, P = .4006).
Conclusions
The present study describes surgical features of H3 K27M-mutated glioma in adulthood in a large multicentric study. Our data reveal that ATRX status, location and KPS significantly impact OS in H3 K27M-mutated glioma. Importantly, our dataset indicates that resection does not offer a survival advantage over biopsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Neurosurgery, University Hospital of Münster, Münster, Germany.
- Department of Neurosurgery, Charité University Hospital Berlin, Berlin, Germany.
- Department of Neurosurgery, Medical Center - University of Freiburg, Freiburg, Germany.
- Department of Neurosurgery, Technical University Munich, Munich, Germany.
- Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
ORCID-Profile: Alice Ryba, Walter Stummer, Manfred Westphal, Ulrich Schüller, Malte Mohme
Zitieren
APA
Ryba, A., Özdemir, Z., Nissimov, N., Hönikl, L., Neidert, N., Jakobs, M., Kalasauskas, D., Krigers, A., Thomé, C., Freyschlag, C. F., Ringel, F., Unterberg, A., Dao Trong, P., Beck, J., Heiland, D. H., Meyer, B., Vajkoczy, P., Onken, J., Stummer, W., …, & Mohme, M. (2024). Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection’s limited influence on overall survival, ATRX as molecular prognosticator. Neuro-Oncology, 26(8), 1479-1493. https://doi.org/10.1093/neuonc/noae061
Vancouver
Ryba A, Özdemir Z, Nissimov N, Hönikl L, Neidert N, Jakobs M, et al. Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection’s limited influence on overall survival, ATRX as molecular prognosticator. Neuro-Oncology. 2024;26(8):1479-1493. doi:10.1093/neuonc/noae061
BibTeX
@article{Ryba2024,
author = {Ryba, Alice and Özdemir, Zeynep and Nissimov, Nitzan and Hönikl, Lisa and Neidert, Nicolas and Jakobs, Martin and Kalasauskas, Darius and Krigers, Aleksandrs and Thomé, Claudius and Freyschlag, Christian F and Ringel, Florian and Unterberg, Andreas and Dao Trong, Philip and Beck, Jürgen and Heiland, Dieter Henrik and Meyer, Bernhard and Vajkoczy, Peter and Onken, Julia and Stummer, Walter and Suero Molina, Eric and Gempt, Jens and Westphal, Manfred and Schüller, Ulrich and Mohme, Malte},
title = {Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection’s limited influence on overall survival, ATRX as molecular prognosticator},
journal = {Neuro-Oncology},
year = {2024},
volume = {26},
number = {8},
pages = {1479--1493},
doi = {10.1093/neuonc/noae061}
}
EUVIMED